HeartFlow is a company that revolutionizes precision heart care by bringing together human ingenuity and advanced technology to help combat heart disease.

HeartFlow

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. 

Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow’s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. 

We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care. 

For more information, visit www.heartflow.com.


Emergent Medical Partners

HealthCor Partners

U.S. Venture Partners

Lifeforce Capital

Capricorn Investment Group

Panorama Point Partners

Baillie Gifford

Wellington Management

Martis Capital

Rancilio Cube

Bain Capital Life Sciences

Hayfin Capital Management

Janus Henderson Investors

HeartFlow, Inc

We're honored to start the month of July off with Poudre Valley Hospital. We recently celebrated their accomplishment of being selected as a Q1 2024 recipient for #HeartFlow's CT Quality Award. Congratulations on your efforts in coronary CT imaging - well done UC Health! 

#FFRCT #CCTA #AI #heartcare #CAD

When asked how to use the plaque analysis report with patients, Dr. Pursnani replied, “Patients really can relate to seeing the plaque...and are more apt to adopt and take the medical therapy that’s prescribed.” https://bit.ly/3TikVAN 

#HeartFlow #HeartFlowPlaqueAnalysis #Plaque

Please join us in congratulating the Ascension St. Vincent team on being awarded a CT Quality Award for Q1 2024. We're honored to be partnered with a team that is steadily dedicated to proviiding quality cardiovascular care to their patients. Amazing job! 

#CCTA #FFRCT #AI #heartcare #yesCCT

Today we are celebrating the CT imaging team over at Northwell Peconic Bay Medical Center. They've been selected as a recipient of #HeartFlow's CT Quality Award for both Q4 2023 and Q1 2024. What an achievement! Your commitment to quality is truly impressive and we look forward to revolutionizing precision heart care with you all. 

#FFRCT #CCTA #AI #heartcare #yesCCT

St. Michael's Medical Center has earned their very first CT Quality Award for Q1 2024! This CT imaging team's hardwork and dedication to their patients is truly showcased in this award. Congratulations on your first award and we look forward to celebrating many more with you all. 

Virginia Mason Franciscan Health #FFRCT #CCTA #AI #heartcare

10 years into the use of #FractionalFlowReserve #FFR derived from #CTCA, 3 early adopters review illustrative cases and share important lessons learned about #LesionSpecificPhysiology. Colin Barker Mark Rabbat MD,FSCCT,FACC,FAHA Jonathon Leipsic

Domain Not Resolving

DNSSEC

IPv6

U.S. Server Location

Facebook Sharer

Amazon Virginia Region

Google AdWords Conversion

Amazon Route 53

Ruby on Rails Token

Stripe

Chief Medical Officer

Campbell Rogers

Founder, Board Member

Charles Taylor

Business Management

John Farquhar

President and Chief Executive Officer, Co-Founder

John Stevens

Chief Commercial Officer

Lance Scott

Chief Financial Officer

Monica Tellado

Owner

Nancy kalbaugh

General Counsel, Chief Ethics & Compliance Officer

Nicky Espinosa

Vice President, Market Access and Reimbursement

Cara Santillo

SVP Engineering

Christophe Lecas

William Weldon

Jeffrey C. Lightcap

Casey Tansey

Lonnie Smith

Julie Cullivan

Wayne Riley

Charles A. Taylor

President & CEO, Co-Founder

Founder and Chief Scientific Officer

Noemi Espinosa

Auston Davis

Vice President & Chief Information Security Officer

Tim Fonte

SVP of Program Leadership

Dustin Michaels

Sr. VP Customer Success & Sr. VP Strategic Accounts

Christopher K. Zarins

Founder & Senior Advisor for Clinical Affairs

Health Care Companies With More Than 10 Employees (Top 10K)

California Late Stage Companies With More Than 50 Employees

Western US Companies With Fewer Than 1000 Employees (Top 10K)

Medical Companies With More Than 100 Employees (Top 10K)

HeartFlow focuses on precision heart care, combining human ingenuity with technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRCT Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.

Series F - HeartFlow

Venture Round - HeartFlow

Series E - HeartFlow

Series D - HeartFlow

Series C - HeartFlow

Series B - HeartFlow

Debt Financing - HeartFlow

Series A - HeartFlow

Seed Round - HeartFlow

Computer and Software Services and Scientific Services

Mountain View

California

United States

North America

Earlier Detection and Treatment are Essential for Meeting VBC Goals

HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform

HeartFlow Touts Study Indicating 63% Mortality Reduction With Its FFRCT-Guided Tech

HeartFlow unveils next-gen plaque analysis AI

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

High Accuracy Rate Found With HeartFlow's Plaque Analysis Tech

HeartFlow Touts Study Indicating 63% Mortality Reduction With its FFRCT-Guided Tech

A non-invasive cardiac test that combines coronary CT angiography (CCTA) images with advanced algorithms to create a personalized 3D model of the coronary arteries, assessing the impact of blockages on blood flow.

A non-invasive cardiac test that combines imaging data with advanced algorithms to create a personalized 3D model of a patient's coronary arteries, assessing blood flow and blockages.

Generates a personalized 3D model of coronary arteries, providing functional information about blood flow and blockages to aid in diagnosis and treatment planning.

Generates a personalized color-coded 3D model of the coronary arteries showing the functional impact of blockages on blood flow, derived from standard CCTA images.

Offers a detailed assessment of plaque composition within the coronary arteries, aiding in the evaluation of coronary artery disease risk.

A tool for physicians to interact with the 3D model of a patient's coronary arteries, aiding in treatment planning by visualizing the impact of potential interventions.

news impact assignment basic	general
public peers	general	Jul 11, 2024 5:47 PM	507f0f96
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 18, 2024 2:12 PM	481ee5e2
crunchbase profile	general	Nov 19, 2024 11:27 AM	0fabe1f3
li profile	general	Jul 11, 2024 5:47 PM	bff0891a
translate crunchbase fundingrounds	general	Nov 19, 2024 1:17 PM	0e3680b8
peers	general	Jul 11, 2024 5:47 PM	12baf346
news basic	general	Jul 11, 2024 5:47 PM	6aa0d8b7
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:HEARTFLOW

HeartFlow